Kabanat is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Kabanat (cabazitaxel) Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Kabanat (cabazitaxel) Injection cost price in India.
The order for Kabanat (cabazitaxel) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Kabanat (cabazitaxel) Injection, 60 mg/1.5 mL, for intravenous infusion only
Generic Name: cabazitaxel
Single use vial 60 mg/1.5 mL, supplied with diluent (5.7 mL)
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Kabanat (cabazitaxel) Injection on prescription and Import License in Patient's Name only.
For overseas patients, Kabanat (cabazitaxel) Injection can be made available in Send your enquiry to find Kabanat (cabazitaxel) Injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Kabanat (cabazitaxel) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Cabazitaxel vs abiraterone or enzalutamide in metastatic prostate cancer For More Details
Addition of Carboplatin to Cabazitaxel Promising for mCRPCReadMore